94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Med.
Sec. Pulmonary Medicine
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1531853
This article is part of the Research Topic Unveiling Distinctions: Active Tuberculosis versus Latent Tuberculosis Infection - Immunological Insights, Biomarkers, and Innovative Approaches View all 3 articles
Mpt64 mutations in Mycobacterium tuberculosis with negative MPT64 antigen assay results from a tertiary hospital in Southeastern China
Provisionally accepted- 1 Department of Biomedical Sciences Laboratory, Dongyang Hospital of Wenzhou Medical University, Dongyang, China
- 2 School of Public Health, Fudan University, Shanghai, Shanghai Municipality, China
- 3 Department of Clinical Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China
- 4 Department of Infectious Diseases, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China
Background: MPT64 protein is an effective marker for detecting Mycobacterium tuberculosis (MTB) in liquid culture and clinical tissue samples. However, some MTB clinical isolates test negative for this antigen because of varied mutation types across different regions. Methods: DNA samples of MPT64 antigen assay-negative MTB strains were collected from a tertiary hospital from January 2016 to January 2024, and mpt64 gene mutations were detected by sequencing. Clinical records of patients with negative MPT64 antigen results were collected and compared with those of patients with positive results. The global distribution of mpt64 gene mutations was analyzed using MTB genome sequences from the National Center for Biotechnology Information (NCBI) database. Results: Among 821 mycobacterial specimens with negative MPT64 antigen assay results, 77 MTB strains were collected from 73 patients. Compared with MPT64-positive patients (n=301), a higher percentage of MPT64-negative patients had a history of anti-tuberculosis therapy (n=7, 11.1%; P=0.01). Moreover, MPT64-negative patients demonstrated a lower percentage of positive Gene Xpert results than MPT64-positive patients (73.8% vs 95.1%, P<0.001). Several gene mutations were detected in the MPT64-negative MTB strains, including 63-bp deletion, single nucleotide mutations, and IS6110 insertion. Among 7,324 MTB genomes from the NCBI database, 87 strains had mutations in the mpt64 gene sequence, with four common mutation sites causing single amino acid changes, including G34A (8.0%), A102G (27.6%), T128A (9.2%), and C477A (24.1%).Conclusion: A negative MPT64 antigen result in MTB cultures can be attributed to mutations in the mpt64 gene, and infections caused by these strains are more likely to be misdiagnosed.
Keywords: Mycobacterium tuberculosis, MPT64, gene mutation, false negative, Clinical features
Received: 21 Nov 2024; Accepted: 18 Feb 2025.
Copyright: © 2025 Pan, Zhou, Jin, Ji, Lou, Lu and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xinling Pan, Department of Biomedical Sciences Laboratory, Dongyang Hospital of Wenzhou Medical University, Dongyang, China
Jin Zhao, Department of Biomedical Sciences Laboratory, Dongyang Hospital of Wenzhou Medical University, Dongyang, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.